There are 2934 resources available
Our profession’s worst nightmare
Presenter: Rick L. Haas
Session: Radiation-associated sarcoma
Resources:
Slides
Webcast
1518 - Molecular classification of the PORTEC-3 trial for high-risk endometrial cancer: impact on adjuvant therapy
Presenter: Carien Creutzberg
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
Poster Discussion – Gynaecological cancers - Invited Discussant 998PD, 999PD and one LBA63
Presenter: Robert Coleman
Session: Poster Discussion – Gynaecological cancers
Resources:
Slides
Webcast
Presentation of case/condition
Presenter: Jesus San-Miguel
Session: Defining optimal response in myeloma
Resources:
Slides
Webcast
Haematology and immunophenotyping
Presenter: Jesus San-Miguel
Session: Defining optimal response in myeloma
Resources:
Slides
Webcast
Imaging
Presenter: Sally Barrington
Session: Defining optimal response in myeloma
Resources:
Slides
Webcast
Presentation by expert
Presenter: Ignacio Melero
Session: How to choose between single agent and combination immunotherapy
Resources:
Slides
Webcast
4350 - Time to second progression (PFS2) and second subsequent therapy (TSST) for patients (pts) with newly diagnosed, advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) treated with maintenance (mt) olaparib (ola) – Phase III SOLO1 trial
Presenter: Ana Oaknin
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
2325 - Patient-centred outcomes with maintenance olaparib in newly diagnosed patients with advanced ovarian cancer (OC) and a BRCA mutation (BRCAm) in the Phase III SOLO1 trial to support the clinical benefit of prolongation of progression-free survival (PFS)
Presenter: Michael Friedlander
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract
2019 - Validation of the Geriatric Vulnerability Score (GVS) in older ovarian cancer (oOC) patients: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study
Presenter: Fabian Tinquaut
Session: Poster Discussion – Gynaecological cancers
Resources:
Abstract